Latest Infant Nutrition News

Page 1 of 2
Australian Dairy Nutritionals has secured firm commitments for a further A$1.54 million placement, taking its broader capital raise to A$2.04 million before costs. The funds are earmarked for operations, working capital and balance sheet support as the company prepares for FY27.
Victor Sage
Victor Sage
30 Oct 2026
Bubs Australia has expanded its US footprint to more than 12,000 stores after securing permanent FDA authorisation, but quarterly revenue fell 9.8% and operating cash outflow increased. The company ended September with A$13.4 million of available liquidity, equivalent to 2.2 quarters at the reported cash-burn rate.
Victor Sage
Victor Sage
29 Oct 2026
Bega Cheese has entered FY2027 with normalised EBITDA guidance of $240 million to $245 million after delivering a sharp improvement in FY2026 earnings. The company expects a relatively flat first half before stronger growth in the second half, supported by branded products, automation and manufacturing savings.
Victor Sage
Victor Sage
21 Oct 2026
Bubs Australia delivered 9.2% revenue growth and a sharp underlying EBITDA improvement in FY26, but statutory losses, weaker margins and negative operating cash flow expose the cost of its expansion. Permanent US FDA authorisation removes a major regulatory hurdle, while the annual report still flags material uncertainty around ongoing funding and cash generation.
Victor Sage
Victor Sage
14 Oct 2026
Nuchev has inked a consignment-based distribution deal to launch the Kuci women’s health probiotic range nationally through Chemist Warehouse, marking a strategic expansion into women’s health.
Ada Torres
Ada Torres
28 Aug 2026
Bubs Australia expects FY26 revenue between $105 million and $115 million, with underlying EBITDA forecast at $4 million to $8 million despite external challenges including regulatory delays and increased air freight costs.
Victor Sage
Victor Sage
29 May 2026
Bubs Australia reports a 14% increase in half-year revenue, powered by a 47% jump in US sales, while other regions face challenges. The company remains optimistic about FDA approval and market recovery in H2 FY26.
Victor Sage
Victor Sage
30 Jan 2026
Nutritional Growth Solutions announces the departure of CEO Stephen J. Turner, appointing Non-Executive Director Andrew Grover as interim CEO to steer the company through its next phase.
Ada Torres
Ada Torres
24 Dec 2025
Bubs Australia Limited reported a solid FY25 with $102.5 million revenue and outlined ambitious FY26 guidance targeting up to $125 million, driven by overseas markets and strategic investments.
Victor Sage
Victor Sage
20 Nov 2025
The a2 Milk Company is expanding its strategic partnership with China State Farm to include English label infant milk formula products, starting with a2 Genesis™ in early 2026. This move aims to strengthen distribution control and capitalize on China’s booming infant formula market.
Victor Sage
Victor Sage
10 Nov 2025
Bubs Australia Limited announces it expects to recover A$825,000 from Willis Trading Limited’s secured creditor following arbitration proceedings, while no further recoveries are anticipated from related parties.
Victor Sage
Victor Sage
6 Nov 2025
Bubs Australia reported a 30% increase in net revenue to $25.6 million for Q1 FY26, driven by robust US sales and a return to profitability with positive EBITDA. Despite inventory challenges in other regions, the company maintains a solid cash position and anticipates FDA approval by year-end.
Victor Sage
Victor Sage
31 Oct 2025

Browse the archive

Full archive